Evelo Biosciences Inc
(OTCPK:EVLO)
$
0.0001
0 (0%)
Market Cap: 2,000.00
Enterprise Value: 16.69 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 0/100 - Evelo Biosciences Inc Extraordinary Shareholders Meeting TranscriptJan 26, 2024
- Evelo Biosciences Inc Clinical Updates Call TranscriptApr 26, 2023
- Q4 2022 Evelo Biosciences Inc Earnings Call TranscriptMar 16, 2023$5.98 (-5.08%)Earnings
- Evelo Biosciences Inc To Provide Business Update TranscriptFeb 01, 2023
- Evelo Biosciences Inc Scientific Basis for SINTAX Medicines in Frontiers in Immunology - Corporate Call TranscriptNov 30, 2022
- Evelo Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 Evelo Biosciences Inc Earnings Call TranscriptAug 11, 2022$57.8 (-2.03%)Earnings
- Q4 2021 Evelo Biosciences Inc Earnings Call TranscriptMar 24, 2022$82.4 (+25.99%)Earnings
- Evelo Biosciences Inc KOL Event - Corporate Call TranscriptMar 11, 2022
- Q3 2021 Evelo Biosciences Inc Earnings Call TranscriptOct 28, 2021$165.4 (+2.99%)Earnings
- Evelo Biosciences Inc EDP1815 Clinical Data Update Call TranscriptSep 27, 2021
- Q2 2021 Evelo Biosciences Inc Earnings Call TranscriptJul 29, 2021$202.2 (+8.83%)Earnings
- Q1 2021 Evelo Biosciences Inc Earnings Call TranscriptApr 29, 2021$244.8 (+1.24%)Earnings
- Q4 2020 Evelo Biosciences Inc Earnings Call TranscriptMar 09, 2021$219 (+11.05%)Earnings
- Evelo Biosciences, Inc. - Special Call TranscriptJan 20, 2021
- Evelo Biosciences, Inc. - Special Call TranscriptDec 09, 2020
- Q3 2020 Evelo Biosciences Inc Earnings Call TranscriptOct 29, 2020$86.8 (-4.82%)Earnings
- Evelo Biosciences, Inc. - Special Call TranscriptOct 22, 2020
- Evelo Biosciences Inc at Morgan Stanley 18th Annual Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Evelo Biosciences Inc Earnings Call TranscriptJul 30, 2020$79.6 (+2.84%)Earnings
- Evelo Biosciences Inc Annual Shareholders Meeting TranscriptJun 17, 2020
- Q1 2020 Evelo Biosciences Inc Earnings Call TranscriptMay 11, 2020$109.6 (+7.87%)Earnings
- Evelo Biosciences, Inc. - Special Call TranscriptMay 07, 2020
- Q4 2019 Evelo Biosciences Inc Earnings Call TranscriptFeb 13, 2020$87.8 (-10.95%)Earnings
- Q3 2019 Evelo Biosciences Inc Earnings Call TranscriptNov 05, 2019$135 (-3.71%)Earnings
- Evelo Biosciences Inc to Host Key Opinion Leader Symposium on Unmet Need in Mild to Moderate Psoriasis and Potential for EDP1815 Call TranscriptOct 04, 2019
- Evelo Biosciences Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q2 2019 Evelo Biosciences Inc Earnings Call TranscriptAug 06, 2019$118 (+5.92%)Earnings
- Q1 2019 Evelo Biosciences Inc Earnings Call TranscriptMay 02, 2019$169.6 (-0.24%)Earnings
- Q4 2018 Evelo Biosciences Inc Earnings Call TranscriptFeb 14, 2019$191.8 (+9.73%)Earnings
Evelo Biosciences Inc at Morgan Stanley Healthcare Conference Transcript
Sep 10, 2019 / 02:35PM GMT
Release Date Price:
$129.6
(-0.77%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director
Good. So thanks, everybody. We're going to get started with the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Just quickly before we get going, I need to read a disclosure statement. Please note that all-important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures or you can pick up a copy at the registration desk. So very pleased to have the team from Evelo here.
Balkrishan Gill
Evelo Biosciences, Inc. - President, CEO & Director
Thank you.
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director
Simba, I don't know if you want to make any opening comments. If not, we'll jump right in, but...
Balkrishan Gill
Evelo Biosciences, Inc. - President, CEO & Director
Jump straight in.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)